Kyntra Bio (KYNB) EV to CFO (2014 - 2026)

Kyntra Bio has disclosed EV to CFO across 13 years of filings, most recently posting 9.84 for Q2 2026.

• In Q2 2026, EV to CFO rose 728.49% year-over-year to 9.84; the TTM figure through Jun 2026 stood at 1.03 (up 260.61% YoY), while the FY2025 annual figure was 6.7, up 2680.76% from the prior year.
• EV to CFO came in at 9.84 for Q2 2026 at Kyntra Bio, up from 2.76 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 37.56 in Q3 2025 to a low of 84.15 in Q1 2022.
• Average EV to CFO over 5 years is 4.25, with a median of 1.24 recorded in 2025.
• Year-over-year, EV to CFO sank 248.03% in 2022 and soared 728.49% in 2026.
• Over 5 years, EV to CFO stood at 20.69 in 2022, then surged by 133.39% to 6.91 in 2023, then slumped by 84.21% to 1.09 in 2024, then surged by 59.91% to 1.74 in 2025, then soared by 464.15% to 9.84 in 2026.
• Per Business Quant data, the three most recent EV to CFO figures were 9.84 in Q2 2026, 2.76 in Q1 2026, and 1.74 in Q4 2025.